Health and Fitness Health and Fitness
Wed, November 16, 2011
Tue, November 15, 2011

Synergetics USA to Strengthen Independent Board Representation


Published on 2011-11-15 13:55:27 - Market Wire
  Print publication without navigation


OaFALLON, Mo.--([ ])--Synergetics USA, Inc. (NASDAQ: SURG), a medical device companythat designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced that it plans to strengthen its independent board member governance at its annual meeting on December 13, 2011.

"As part of our plan, we will reduce the number of inside directors to one, Dave Hable, Synergeticsa President and CEO, and the remainder of our Board Members will be independent."

aWe plan to improve our ratio of independent directors compared to inside directors at Synergetics USA effective with our annual meeting in December so that our governance platform will be in line with corporate best practices,a stated Robert Dick, Chairman of the Board of Directors. aAs part of our plan, we will reduce the number of inside directors to one, Dave Hable, Synergeticsa President and CEO, and the remainder of our Board Members will be independent.

aWe added Graeme Thomas and Patricia Williams as independent board members in August of this year and increased our total Board to nine members. Effective with our annual meeting in December, Kurt W. Gampp, Jr., Synergeticsa Executive Vice President and Chief Operating Officer and Jerry L. Malis, Synergeticsa Executive Vice President and Chief Scientific Officer, will be rolling off the board and we will reduce our total Board membership to seven, six of whom will be independent. We believe our shift to a more independent board will improve our corporate governance platform while allowing key executives to focus on executing our Companyas strategic growth plans. Kurt and Jerry are in full agreement with the Boardas decision not to re-nominate them to another term. The Board appreciates the contributions Kurt and Jerry have made over the course of many years of active participation in Board discussions and important decisions. The Board will continue to benefit from their counsel and we look forward to their continuing leadership of the Company,a concluded Mr. Dick.

About Synergetics USA, Inc.

Through continuous improvement and development of our people, our mission is to design, manufacture and marketinnovative surgical devices, capital equipment, accessories and disposables of the highest quality in order to assist and enable surgeons who perform surgery around the world to provide a better quality of life for their patients.

Synergetics USA, Inc. (the aCompanya) is a leading supplier of precision surgical devices. The Companyas primary focus is on the disciplines of ophthalmology and neurosurgery. Our distribution channels include a combination of direct and independent sales distribution organizations and important strategic alliances withmarket leaders. The Companyas product lines focus upon precision engineered, disposable and reusable devices, procedural kits and the delivery of various energy modalities for the performance of lessinvasive surgery including: (i) laser energy, (ii)ultrasonic energy, (iii) radio frequency energy forelectrosurgery and lesion generation and (iv)visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. The Companyas website address is [ http://www.synergeticsusa.com ].

Forward-Looking Statements

Some statements in this release may be aforward-looking statementsa for the purposes of the Private Securities Litigation Reform Act of 1995.In some cases forward-looking statements can be identified by words such as abelieve,a aexpect,a aanticipate,a aplan,a apotential,a acontinuea or similar expressions.Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements.These factors, risks and uncertainties are discussed in the Companyas Annual Report on Form 10-K for the year ended July31, 2011, as updated from time to time in our filings with the Securities and Exchange Commission.The Company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.

Contributing Sources